APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ondansetron Hydrochloride for Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ondansetron Hydrochloride for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025195 pages

Choose your research edition.

Industry ResearchOndansetron Hydrochloride for Injection Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Ondansetron Hydrochloride for Injection Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Ondansetron Hydrochloride for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ondansetron Hydrochloride for Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Ondansetron Hydrochloride for Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ondansetron Hydrochloride for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ondansetron Hydrochloride for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ondansetron Hydrochloride for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ondansetron Hydrochloride for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ondansetron Hydrochloride for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ondansetron Hydrochloride for Injection include Fresenius, Hikma Pharmaceuticals, Intas Pharmaceuticals, Laboratorios Normon, Maruishi Pharmaceutical, Viatris, Fuan Pharmaceutical, Harbin Medisan Pharmaceutical and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ondansetron Hydrochloride for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ondansetron Hydrochloride for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ondansetron Hydrochloride for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ondansetron Hydrochloride for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Ondansetron Hydrochloride for Injection Segment by Company

Fresenius

Hikma Pharmaceuticals

Intas Pharmaceuticals

Laboratorios Normon

Maruishi Pharmaceutical

Viatris

Fuan Pharmaceutical

Harbin Medisan Pharmaceutical

Novartis

Qilu Pharmaceutical

Beijing Sciecure Pharmaceutical

Ondansetron Hydrochloride for Injection Segment by Type

2ml

4ml

Other

Ondansetron Hydrochloride for Injection Segment by Application

Clinic

Hospital

Others

Ondansetron Hydrochloride for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ondansetron Hydrochloride for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ondansetron Hydrochloride for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ondansetron Hydrochloride for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ondansetron Hydrochloride for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ondansetron Hydrochloride for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ondansetron Hydrochloride for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ondansetron Hydrochloride for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ondansetron Hydrochloride for Injection Industry Trends Table 2. Ondansetron Hydrochloride for Injection Industry Drivers Table 3. Ondansetron Hydrochloride for Injection Industry Opportunities and Challenges Table 4. Ondansetron Hydrochloride for Injection Industry Restraints Table 5. Global Ondansetron Hydrochloride for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ondansetron Hydrochloride for Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Ondansetron Hydrochloride for Injection Sales Market Share by Manufacturers Table 9. Global Ondansetron Hydrochloride for Injection Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Ondansetron Hydrochloride for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ondansetron Hydrochloride for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ondansetron Hydrochloride for Injection Manufacturers, Product Type & Application Table 13. Global Ondansetron Hydrochloride for Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ondansetron Hydrochloride for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2ml Table 17. Major Manufacturers of 4ml Table 18. Major Manufacturers of Other Table 19. Global Ondansetron Hydrochloride for Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Ondansetron Hydrochloride for Injection Sales by Type (2021-2026) & (k units) Table 21. Global Ondansetron Hydrochloride for Injection Sales by Type (2027-2032) & (k units) Table 22. Global Ondansetron Hydrochloride for Injection Sales Market Share by Type (2021-2026) Table 23. Global Ondansetron Hydrochloride for Injection Sales Market Share by Type (2027-2032) Table 24. Global Ondansetron Hydrochloride for Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Ondansetron Hydrochloride for Injection Revenue by Type (2021-2026) & (k units) Table 26. Global Ondansetron Hydrochloride for Injection Revenue by Type (2027-2032) & (k units) Table 27. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Type (2021-2026) Table 28. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Others Table 32. Global Ondansetron Hydrochloride for Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Ondansetron Hydrochloride for Injection Sales by Application (2021-2026) & (k units) Table 34. Global Ondansetron Hydrochloride for Injection Sales by Application (2027-2032) & (k units) Table 35. Global Ondansetron Hydrochloride for Injection Sales Market Share by Application (2021-2026) Table 36. Global Ondansetron Hydrochloride for Injection Sales Market Share by Application (2027-2032) Table 37. Global Ondansetron Hydrochloride for Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Ondansetron Hydrochloride for Injection Revenue by Application (2021-2026) & (k units) Table 39. Global Ondansetron Hydrochloride for Injection Revenue by Application (2027-2032) & (k units) Table 40. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Application (2021-2026) Table 41. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Application (2027-2032) Table 42. Global Ondansetron Hydrochloride for Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Ondansetron Hydrochloride for Injection Sales by Region (2021-2026) & (k units) Table 44. Global Ondansetron Hydrochloride for Injection Sales Market Share by Region (2021-2026) Table 45. Global Ondansetron Hydrochloride for Injection Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Ondansetron Hydrochloride for Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Ondansetron Hydrochloride for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Ondansetron Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 49. North America Ondansetron Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 50. Europe Ondansetron Hydrochloride for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Ondansetron Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 52. Europe Ondansetron Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Ondansetron Hydrochloride for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Ondansetron Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Ondansetron Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Ondansetron Hydrochloride for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Ondansetron Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Ondansetron Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 59. Global Ondansetron Hydrochloride for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Ondansetron Hydrochloride for Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Ondansetron Hydrochloride for Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Region (2021-2026) Table 63. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Region (2027-2032) Table 64. Fresenius Company Information Table 65. Fresenius Business Overview Table 66. Fresenius Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Fresenius Ondansetron Hydrochloride for Injection Product Portfolio Table 68. Fresenius Recent Development Table 69. Hikma Pharmaceuticals Company Information Table 70. Hikma Pharmaceuticals Business Overview Table 71. Hikma Pharmaceuticals Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Hikma Pharmaceuticals Ondansetron Hydrochloride for Injection Product Portfolio Table 73. Hikma Pharmaceuticals Recent Development Table 74. Intas Pharmaceuticals Company Information Table 75. Intas Pharmaceuticals Business Overview Table 76. Intas Pharmaceuticals Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Intas Pharmaceuticals Ondansetron Hydrochloride for Injection Product Portfolio Table 78. Intas Pharmaceuticals Recent Development Table 79. Laboratorios Normon Company Information Table 80. Laboratorios Normon Business Overview Table 81. Laboratorios Normon Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Laboratorios Normon Ondansetron Hydrochloride for Injection Product Portfolio Table 83. Laboratorios Normon Recent Development Table 84. Maruishi Pharmaceutical Company Information Table 85. Maruishi Pharmaceutical Business Overview Table 86. Maruishi Pharmaceutical Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Maruishi Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio Table 88. Maruishi Pharmaceutical Recent Development Table 89. Viatris Company Information Table 90. Viatris Business Overview Table 91. Viatris Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Viatris Ondansetron Hydrochloride for Injection Product Portfolio Table 93. Viatris Recent Development Table 94. Fuan Pharmaceutical Company Information Table 95. Fuan Pharmaceutical Business Overview Table 96. Fuan Pharmaceutical Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Fuan Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio Table 98. Fuan Pharmaceutical Recent Development Table 99. Harbin Medisan Pharmaceutical Company Information Table 100. Harbin Medisan Pharmaceutical Business Overview Table 101. Harbin Medisan Pharmaceutical Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Harbin Medisan Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio Table 103. Harbin Medisan Pharmaceutical Recent Development Table 104. Novartis Company Information Table 105. Novartis Business Overview Table 106. Novartis Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Novartis Ondansetron Hydrochloride for Injection Product Portfolio Table 108. Novartis Recent Development Table 109. Qilu Pharmaceutical Company Information Table 110. Qilu Pharmaceutical Business Overview Table 111. Qilu Pharmaceutical Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Qilu Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio Table 113. Qilu Pharmaceutical Recent Development Table 114. Beijing Sciecure Pharmaceutical Company Information Table 115. Beijing Sciecure Pharmaceutical Business Overview Table 116. Beijing Sciecure Pharmaceutical Ondansetron Hydrochloride for Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Beijing Sciecure Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio Table 118. Beijing Sciecure Pharmaceutical Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Ondansetron Hydrochloride for Injection Distributors List Table 122. Ondansetron Hydrochloride for Injection Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Ondansetron Hydrochloride for Injection Product Image Figure 2. Global Ondansetron Hydrochloride for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ondansetron Hydrochloride for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ondansetron Hydrochloride for Injection Sales (2021-2032) & (k units) Figure 5. Global Ondansetron Hydrochloride for Injection Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ondansetron Hydrochloride for Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2ml Image Figure 9. 4ml Image Figure 10. Other Image Figure 11. Global Ondansetron Hydrochloride for Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Ondansetron Hydrochloride for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Ondansetron Hydrochloride for Injection Sales Market Share by Type (2021-2032) Figure 14. Global Ondansetron Hydrochloride for Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Ondansetron Hydrochloride for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Others Image Figure 20. Global Ondansetron Hydrochloride for Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Ondansetron Hydrochloride for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Ondansetron Hydrochloride for Injection Sales Market Share by Application (2021-2032) Figure 23. Global Ondansetron Hydrochloride for Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Ondansetron Hydrochloride for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Ondansetron Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Ondansetron Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Ondansetron Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 40. China Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Ondansetron Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Ondansetron Hydrochloride for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Ondansetron Hydrochloride for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Ondansetron Hydrochloride for Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Ondansetron Hydrochloride for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Ondansetron Hydrochloride for Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Ondansetron Hydrochloride for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Ondansetron Hydrochloride for Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Ondansetron Hydrochloride for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Ondansetron Hydrochloride for Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Ondansetron Hydrochloride for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Ondansetron Hydrochloride for Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Ondansetron Hydrochloride for Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 2ml
  • 4ml
  • Other
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Fresenius
  • Hikma Pharmaceuticals
  • Intas Pharmaceuticals
  • Laboratorios Normon
  • Maruishi Pharmaceutical
  • Viatris
  • Fuan Pharmaceutical
  • Harbin Medisan Pharmaceutical
  • Novartis
  • Qilu Pharmaceutical
  • Beijing Sciecure Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ondansetron Hydrochloride for Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ondansetron Hydrochloride for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ondansetron Hydrochloride for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ondansetron Hydrochloride for Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ondansetron Hydrochloride for Injection Market Dynamics
  1. 2.1 Ondansetron Hydrochloride for Injection Industry Trends
  2. 2.2 Ondansetron Hydrochloride for Injection Industry Drivers
  3. 2.3 Ondansetron Hydrochloride for Injection Industry Opportunities and Challenges
  4. 2.4 Ondansetron Hydrochloride for Injection Industry Restraints
3 Ondansetron Hydrochloride for Injection Market by Manufacturers
  1. 3.1 Global Ondansetron Hydrochloride for Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ondansetron Hydrochloride for Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ondansetron Hydrochloride for Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ondansetron Hydrochloride for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ondansetron Hydrochloride for Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ondansetron Hydrochloride for Injection Manufacturers, Product Type & Application
  7. 3.7 Global Ondansetron Hydrochloride for Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ondansetron Hydrochloride for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ondansetron Hydrochloride for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ondansetron Hydrochloride for Injection Tier 1, Tier 2, and Tier 3
4 Ondansetron Hydrochloride for Injection Market by Type
  1. 4.1 Ondansetron Hydrochloride for Injection Type Introduction
  2. 4.1.1 2ml
  3. 4.1.2 4ml
  4. 4.1.3 Other
  5. 4.2 Global Ondansetron Hydrochloride for Injection Sales by Type
  6. 4.2.1 Global Ondansetron Hydrochloride for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ondansetron Hydrochloride for Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Ondansetron Hydrochloride for Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Ondansetron Hydrochloride for Injection Revenue by Type
  10. 4.3.1 Global Ondansetron Hydrochloride for Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ondansetron Hydrochloride for Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Ondansetron Hydrochloride for Injection Revenue Market Share by Type (2021-2032)
5 Ondansetron Hydrochloride for Injection Market by Application
  1. 5.1 Ondansetron Hydrochloride for Injection Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Ondansetron Hydrochloride for Injection Sales by Application
  6. 5.2.1 Global Ondansetron Hydrochloride for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ondansetron Hydrochloride for Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Ondansetron Hydrochloride for Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Ondansetron Hydrochloride for Injection Revenue by Application
  10. 5.3.1 Global Ondansetron Hydrochloride for Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ondansetron Hydrochloride for Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Ondansetron Hydrochloride for Injection Revenue Market Share by Application (2021-2032)
6 Global Ondansetron Hydrochloride for Injection Sales by Region
  1. 6.1 Global Ondansetron Hydrochloride for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ondansetron Hydrochloride for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Ondansetron Hydrochloride for Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Ondansetron Hydrochloride for Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ondansetron Hydrochloride for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ondansetron Hydrochloride for Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ondansetron Hydrochloride for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ondansetron Hydrochloride for Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ondansetron Hydrochloride for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ondansetron Hydrochloride for Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ondansetron Hydrochloride for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ondansetron Hydrochloride for Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ondansetron Hydrochloride for Injection Revenue by Region
  1. 7.1 Global Ondansetron Hydrochloride for Injection Revenue by Region
  2. 7.1.1 Global Ondansetron Hydrochloride for Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ondansetron Hydrochloride for Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Ondansetron Hydrochloride for Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Ondansetron Hydrochloride for Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ondansetron Hydrochloride for Injection Revenue (2021-2032)
  8. 7.2.2 North America Ondansetron Hydrochloride for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ondansetron Hydrochloride for Injection Revenue (2021-2032)
  11. 7.3.2 Europe Ondansetron Hydrochloride for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ondansetron Hydrochloride for Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ondansetron Hydrochloride for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ondansetron Hydrochloride for Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ondansetron Hydrochloride for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Fresenius
  2. 8.1.1 Fresenius Company Information
  3. 8.1.2 Fresenius Business Overview
  4. 8.1.3 Fresenius Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Fresenius Ondansetron Hydrochloride for Injection Product Portfolio
  6. 8.1.5 Fresenius Recent Developments
  7. 8.2 Hikma Pharmaceuticals
  8. 8.2.1 Hikma Pharmaceuticals Company Information
  9. 8.2.2 Hikma Pharmaceuticals Business Overview
  10. 8.2.3 Hikma Pharmaceuticals Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hikma Pharmaceuticals Ondansetron Hydrochloride for Injection Product Portfolio
  12. 8.2.5 Hikma Pharmaceuticals Recent Developments
  13. 8.3 Intas Pharmaceuticals
  14. 8.3.1 Intas Pharmaceuticals Company Information
  15. 8.3.2 Intas Pharmaceuticals Business Overview
  16. 8.3.3 Intas Pharmaceuticals Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Intas Pharmaceuticals Ondansetron Hydrochloride for Injection Product Portfolio
  18. 8.3.5 Intas Pharmaceuticals Recent Developments
  19. 8.4 Laboratorios Normon
  20. 8.4.1 Laboratorios Normon Company Information
  21. 8.4.2 Laboratorios Normon Business Overview
  22. 8.4.3 Laboratorios Normon Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Laboratorios Normon Ondansetron Hydrochloride for Injection Product Portfolio
  24. 8.4.5 Laboratorios Normon Recent Developments
  25. 8.5 Maruishi Pharmaceutical
  26. 8.5.1 Maruishi Pharmaceutical Company Information
  27. 8.5.2 Maruishi Pharmaceutical Business Overview
  28. 8.5.3 Maruishi Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Maruishi Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio
  30. 8.5.5 Maruishi Pharmaceutical Recent Developments
  31. 8.6 Viatris
  32. 8.6.1 Viatris Company Information
  33. 8.6.2 Viatris Business Overview
  34. 8.6.3 Viatris Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Viatris Ondansetron Hydrochloride for Injection Product Portfolio
  36. 8.6.5 Viatris Recent Developments
  37. 8.7 Fuan Pharmaceutical
  38. 8.7.1 Fuan Pharmaceutical Company Information
  39. 8.7.2 Fuan Pharmaceutical Business Overview
  40. 8.7.3 Fuan Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fuan Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio
  42. 8.7.5 Fuan Pharmaceutical Recent Developments
  43. 8.8 Harbin Medisan Pharmaceutical
  44. 8.8.1 Harbin Medisan Pharmaceutical Company Information
  45. 8.8.2 Harbin Medisan Pharmaceutical Business Overview
  46. 8.8.3 Harbin Medisan Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Harbin Medisan Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio
  48. 8.8.5 Harbin Medisan Pharmaceutical Recent Developments
  49. 8.9 Novartis
  50. 8.9.1 Novartis Company Information
  51. 8.9.2 Novartis Business Overview
  52. 8.9.3 Novartis Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Ondansetron Hydrochloride for Injection Product Portfolio
  54. 8.9.5 Novartis Recent Developments
  55. 8.10 Qilu Pharmaceutical
  56. 8.10.1 Qilu Pharmaceutical Company Information
  57. 8.10.2 Qilu Pharmaceutical Business Overview
  58. 8.10.3 Qilu Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qilu Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio
  60. 8.10.5 Qilu Pharmaceutical Recent Developments
  61. 8.11 Beijing Sciecure Pharmaceutical
  62. 8.11.1 Beijing Sciecure Pharmaceutical Company Information
  63. 8.11.2 Beijing Sciecure Pharmaceutical Business Overview
  64. 8.11.3 Beijing Sciecure Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Sciecure Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio
  66. 8.11.5 Beijing Sciecure Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ondansetron Hydrochloride for Injection Value Chain Analysis
  2. 9.1.1 Ondansetron Hydrochloride for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ondansetron Hydrochloride for Injection Production Mode & Process
  6. 9.2 Ondansetron Hydrochloride for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ondansetron Hydrochloride for Injection Distributors
  9. 9.2.3 Ondansetron Hydrochloride for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst